Home > Core technology > Globally Pioneering Scalable High-Purity Retrovirus Vector Technology
The company holds independent intellectual property rights for the globally pioneering scalable high-purity retrovirus purification process. The high-purity retrovirus enables transduction to produce products with higher purity and greater safety, at lower production costs and with highly competitive commercial pricing.